Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,884
datasets available to search
ShareScore release 0.9.0
Dataset results
2,884 results for “cancer resistance”
Early Switch From First-Line Docetaxel/Prednisone to Cabazitaxel/Prednisone and the Opposite Sequence, Exploring Molecular Markers in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
ClinicalTrials.gov study NCT01718353. IPD Sharing: Not stated. Countries: 2. Publications: 2.
A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancer
ClinicalTrials.gov study NCT01331083. IPD Sharing: NO. Countries: 1. Publications: 1.
Dose-finding Study in Platinum-Resistant Ovarian Cancer
ClinicalTrials.gov study NCT01653912. IPD Sharing: Not stated. Countries: 3. Publications: 1.
A Study to Determine Safety and Tolerability of Enzalutamide (MDV3100) in Combination With Abiraterone Acetate in Bone Metastatic Castration-Resistant Prostate Cancer Patients
ClinicalTrials.gov study NCT01650194. IPD Sharing: YES. Countries: 1. Publications: 1.
Biomarker-Driven Therapy With Nivolumab and Ipilimumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Expressing AR-V7
ClinicalTrials.gov study NCT02601014. IPD Sharing: NO. Countries: 1. Publications: 2.
Pembrolizumab Combined With PLD For Recurrent Platinum Resistant Ovarian, Fallopian Tube Or Peritoneal Cancer
ClinicalTrials.gov study NCT02865811. IPD Sharing: NO. Countries: 1. Publications: 1.
Standard Dose Versus High Dose and Versus Extended Standard Dose Radium-223 Dichloride in Castration-resistant Prostate Cancer Metastatic to the Bone
ClinicalTrials.gov study NCT02023697. IPD Sharing: Not stated. Countries: 15. Publications: 1.
A Study of Sipuleucel-T With Administration of Enzalutamide in Men With Metastatic Castrate-Resistant Prostate Cancer
ClinicalTrials.gov study NCT01981122. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Pembrolizumab (MK-3475) Plus Docetaxel Versus Placebo Plus Docetaxel in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-921/KEYNOTE-921)
ClinicalTrials.gov study NCT03834506. IPD Sharing: YES. Countries: 21. Publications: 2.
Efficacy and Safety Study of Darolutamide (ODM-201) in Men With High-risk Non-metastatic Castration-resistant Prostate Cancer
ClinicalTrials.gov study NCT02200614. IPD Sharing: Not stated. Countries: 36. Publications: 11.
A Study of Alpharadin With Docetaxel in Patients With Bone Metastasis From Castration-Resistant Prostate Cancer (CRPC)
ClinicalTrials.gov study NCT01106352. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Study Comparing Orteronel Plus Prednisone in Participants With Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer
ClinicalTrials.gov study NCT01193244. IPD Sharing: Not stated. Countries: 40. Publications: 3.
Trial of Decitabine as a Sensitizer to Carboplatin in Platinum Resistant Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT00477386. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Pertuzumab in Platinum-Resistant Low Human Epidermal Growth Factor Receptor 3 (HER3) Messenger Ribonucleic Acid (mRNA) Epithelial Ovarian Cancer (PENELOPE)
ClinicalTrials.gov study NCT01684878. IPD Sharing: Not stated. Countries: 10. Publications: 1.
Phase 1/2 Study of Motolimod, Doxorubicin, and Durvalumab in Recurrent, Platinum-Resistant Ovarian Cancer
ClinicalTrials.gov study NCT02431559. IPD Sharing: NO. Countries: 2. Publications: 1.
Study of Enzalutamide in Patients With Castration-resistant Prostate Cancer
ClinicalTrials.gov study NCT01942837. IPD Sharing: NO. Countries: 1. Publications: 1.
A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer
ClinicalTrials.gov study NCT01322490. IPD Sharing: Not stated. Countries: 16. Publications: 1.
A Positron Emission Tomography/Computed Tomography (PET/CT) Bone Imaging Study in Patients Receiving Enzalutamide for Castration-Resistant Prostate Cancer (CRPC)
ClinicalTrials.gov study NCT02384382. IPD Sharing: YES. Countries: 1. Publications: 1.
Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65)
ClinicalTrials.gov study NCT05116189. IPD Sharing: YES. Countries: 25. Publications: 1.
Cabozantinib (XL184) in Men With Castrate-Resistant Prostate Cancer
ClinicalTrials.gov study NCT01347788. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.